olprinone has been researched along with Ventricular Dysfunction, Left in 1 studies
olprinone: RN refers to HCl; structure given in first source
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takaoka, H | 1 |
| Takeuchi, M | 1 |
| Hata, K | 1 |
| Hayashi, Y | 1 |
| Mori, M | 1 |
| Yamakawa, H | 1 |
| Yamaguchi, K | 1 |
| Yokoyama, M | 1 |
1 other study available for olprinone and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Huma | 1997 |